Current status and new progress of drug therapy for premature ejaculation
10.3969/j.issn.1009-8291.2023.05.017
- VernacularTitle:早泄药物治疗的现状及新进展
- Author:
Shihao SHANG
1
;
Lei ZHANG
2
;
Jun LU
2
;
Xinlong DUN
2
;
Xuexue ZHANG
3
;
Jianlin YUAN
2
Author Information
1. The Cadet Team 6 of School of Basic Medicine, Air Force Medical University, Xi’an 710032
2. Department of Urology, Xijing Hospital, Air Force Medical University, Xi’an 710032
3. Department of Urology, Xi’an Daxing Hospital, Yan’an University, Xi’an 710016, China
- Publication Type:Journal Article
- Keywords:
premature ejaculation;
drug treatment;
new drug research and development;
sexual dysfunction
- From:
Journal of Modern Urology
2023;28(5):445-449
- CountryChina
- Language:Chinese
-
Abstract:
Premature ejaculation (PE) is the most common male sexual dysfunction with a high incidence, which seriously affects the relationship between a husband and wife and family harmony. Drug therapy is a first-line treatment for PE patients with premature ejaculation, and has achieved good efficacy, but the clinically available drugs are single and the abandonment rate is high. Coupled with the ineffective treatment of some patients, new drug research and development is imminent. This paper systematically reviews the current status of drug treatment for premature ejaculation, focusing on the research and development of new drugs and research progress in order to provide a reference for clinicians.
